Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Unrealized Gain (Loss) on Investments |
The following table presents the Company’s restricted cash equivalents and restricted investments as of June 30, 2025. The Company did not invest in similar investments during 2024. | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | Amortized Cost Basis | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Money market funds | $ | 1,079,249 | | | $ | — | | | $ | — | | | $ | 1,079,249 | | | Corporate bonds | 994,366 | | | 5,477 | | | (74) | | | 999,769 | | | U.S. government obligations | 22,334,027 | | | 93,003 | | | (1,277) | | | 22,425,753 | | | Total | $ | 24,407,642 | | | $ | 98,480 | | | $ | (1,351) | | | $ | 24,504,771 | | | | | | | | | | | Included in restricted cash and cash equivalents | $ | 4,390,251 | | | $ | 197 | | | $ | (4) | | | $ | 4,390,444 | | | Included in restricted investments | $ | 20,017,391 | | | $ | 98,283 | | | $ | (1,347) | | | $ | 20,114,327 | |
|
| Schedule of Investments Classified by Contractual Maturity Date |
The following table summarizes the contractual maturities of the Company’s restricted cash equivalents and restricted investments as of June 30, 2025: | | | | | | | | | | | | | Amortized Cost | | Fair Value | | Within 1 year | $ | 10,203,010 | | | $ | 10,201,997 | | | After 1 year through 5 years | 8,332,165 | | | 8,369,816 | | | After 5 years through 10 years | 5,872,467 | | | 5,932,958 | | | Total | $ | 24,407,642 | | | $ | 24,504,771 | |
|
| Schedule of Estimated Useful Lives |
A summary of estimated useful lives is as follows: | | | | | | | | | | | Estimated Useful Life | | Buildings | | 39 years | | Office equipment and furniture | | 3-7 years | | Vehicles | | 5-8 years | | Medical equipment | | 5 years | | Leasehold improvements | | Shorter of useful life of asset or lease term |
|
| Schedule of Disaggregation of Revenue |
In the following table, revenues are disaggregated as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Revenue Breakdown | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | Primary Geographical Markets | | | | | | | | | | U.S. | | $ | 66,258,565 | | | $ | 150,788,574 | | | $ | 148,232,981 | | | $ | 329,899,420 | | | U.K. | | 14,159,057 | | | 14,161,142 | | | 28,217,696 | | | 27,137,825 | | | Total revenues | | $ | 80,417,622 | | | $ | 164,949,716 | | | $ | 176,450,677 | | | $ | 357,037,245 | | | | | | | | | | | | Major Segments | | | | | | | | | | Mobile health services | | $ | 30,780,993 | | | $ | 116,742,328 | | | $ | 75,990,537 | | | $ | 260,683,486 | | | Transportation services | | 49,636,629 | | | 48,207,388 | | | 100,460,140 | | | 96,353,759 | | | Total revenues | | $ | 80,417,622 | | | $ | 164,949,716 | | | $ | 176,450,677 | | | $ | 357,037,245 | |
|
| Schedule of Earnings Per Share, Basic and Diluted |
The following table presents the calculation of basic and diluted net (loss) income per share to stockholders of DocGo Inc. and Subsidiaries: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries | $ | (11,155,246) | | | $ | 6,529,603 | | | $ | (20,560,561) | | | $ | 17,757,052 | | | Weighted-average shares outstanding - Basic | 98,931,293 | | | 101,840,612 | | | 100,255,877 | | | 102,829,487 | | | Effect of dilutive options | — | | | 4,483,733 | | | — | | | 4,483,733 | | | Weighted-average shares outstanding - Diluted | 98,931,293 | | | 106,324,345 | | | 100,255,877 | | | 107,313,220 | | | Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic | $ | (0.11) | | | $ | 0.06 | | | $ | (0.21) | | | $ | 0.17 | | | Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Diluted | $ | (0.11) | | | $ | 0.06 | | | $ | (0.21) | | | $ | 0.17 | | | Anti-dilutive employee share-based awards excluded | 13,339,305 | | | 7,486,776 | | | 13,339,305 | | | 7,486,776 | |
|